Compare Air Products & Chemicals, Inc. (APD) vs Charles River Laboratories Intl. Inc (CRL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Air Products & Chemicals, Inc. vs Charles River Laboratories Intl. Inc — how do they compare? Air Products & Chemicals, Inc. trades at $308.56 (market cap $68.88B), while Charles River Laboratories Intl. Inc trades at $287.99 (market cap $13.46B). The key difference: Air Products & Chemicals, Inc. is far larger — about 5.1× Charles River Laboratories Intl. Inc's market cap, and Air Products & Chemicals, Inc. pays a 2.34% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| APD | CRL | |
|---|---|---|
Market Cap | $68.88B | $13.46B |
Sector | Basic Materials | Health |
52-Week High | $314.19 | $282.00 |
52-Week Low | $230.42 | $145.57 |
Enterprise Value | $86.06B | $16.30B |
Dividend Yield | 2.34% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Air Products & Chemicals, Inc.
Since its founding in 1940, Air Products has become one of the leading industrial gas suppliers globally, with operations in 50 countries and 19,000 employees. The company is the largest supplier of hydrogen and helium in the world. It has a unique portfolio serving customers in a number of industries, including chemicals, energy, healthcare, metals, and electronics. Air Products generated $10.3 billion in revenue in fiscal 2021.
Read more on APD →About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →
